Biohm Technologies
Cleveland
About Biohm Technologies
Biohm Technologies is the first microbiome company to address the critical role of fungi in digestive health. The company offers a selection of whole probiotics and gut microbiome testing. After over 20 years of research supported by the National Institutes of Health (NIH), Dr. Ghannoum’s work on the microbiome has converged into one of the biggest discoveries in digestive health. The discovery is how bad bacteria and bad fungus work together to create digestive plaque. This destructive film protects bad bacteria and bad fungi as they work to upset the balance of your digestive system. His solution marked the dawning of a new generation of probiotics with dual-action technology that first breaks open digestive plaque, and then neutralizes the bad bacteria and bad fungi, which allows the gut to maintain its natural microbiome balance, ultimately supporting optimal digestive health.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $13.0M
- Funding stage: Early Stage Venture
- Last round: Series B (Apr 2025)
- Website: biohmtechnologies.com
- Phone: (216) 394-0544
Industries & Categories
Fitness, Health Care, Wellness
Social Profiles
Canonical: https://fsome.com/organization/biohm-technologies-92870 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.